Laboré
First page of the published paper: Comparative Profile of Microbiome in Normal Skin and Acne Vulgaris Skin Patients
Microbiome Congress Asia · 2024

Comparative Profile of Microbiome in Normal Skin and Acne Vulgaris Skin Patients

Sitohang I.B.S., Legiawati L., Widaty S., Nilasari H., Agustin T., Chairunnisa S., Manurung T.H.P.

Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo National Central General Hospital

MicrobiomeAcne

Abstract

Acne vulgaris is linked to shifts in the skin microbiome, but the contribution of individual species has remained unsettled. Using 16S rRNA sequencing of cheek samples from acne patients and healthy controls, this study found markedly lower microbial diversity and a higher prevalence of Staphylococcus epidermidis in acne-prone skin, building the scientific foundation for Laboré's AcneProBiome Series and microbiome-based acne care.

Key findings

  • 144 participants recruited — 108 with acne vulgaris and 36 controls — of whom 92 and 31 respectively passed sequencing quality control
  • Shannon diversity index significantly lower in acne vulgaris than in controls (2.4 vs 2.96; p < 0.001), indicating dysbiosis
  • Relative abundance of Cutibacterium acnes did not differ between groups (31.8% vs 29.5%; p = 0.83)
  • Staphylococcus epidermidis significantly more abundant in acne vulgaris (0.2% vs 0.1%; p = 0.02); Staphylococcus aureus was absent from every sample
  • Sebum output correlated negatively with microbial diversity (r = −0.285; p < 0.001) and positively with S. epidermidis (r = 0.233; p = 0.01)
  • 9,073,415 sequencing reads across all samples resolved 1,451 unique operational taxonomic units

Methods at a glance

Study type
Comparative cross-sectional microbiome profiling
Participants
144 recruited: 108 with acne vulgaris, 36 controls
Analysed
92 acne and 31 control samples passed the 1,000-read threshold
Recruitment
November 2022 to March 2023
Sampling
Left cheek, sterile swab in DNA/RNA Shield across a 4 × 4 cm area for ~50 seconds; stored at −80°C within 24 hours
Sequencing
DNeasy PowerSoil extraction, V3–V4 region of 16S rRNA, Nextera XT indexing, Illumina MiSeq
Bioinformatics
QIIME 1.7.0 with USEARCH filtering; OTUs above 0.1% in a sample and present in at least 20% of samples
Registration
ClinicalTrials.gov NCT05838534; ethics KET-482/UN2.F1/ETIK/PPM.00.02/2022

Background

Resident microorganisms on the skin contribute to its barrier function, and alterations in their composition have been associated with a range of skin conditions including acne vulgaris. Acne develops through increased sebum production, abnormal follicular keratinisation, bacterial colonisation and inflammation. Cutibacterium acnes, abundant in sebaceous areas, has long been proposed as the causative organism, yet studies have produced conflicting results and it is not consistently elevated in acne-affected skin. Attention has therefore shifted to dysbiosis — an imbalance across the whole skin microbiome — which may affect innate and adaptive immune responses within pilosebaceous follicles. While Staphylococcus aureus and Staphylococcus epidermidis have been studied in some depth, many minor skin organisms remain uncharacterised.

Objective

To compare skin microbiome profiles between acne vulgaris patients and healthy individuals, and to explore associations with microbial diversity and with the specific bacterial populations implicated in acne pathogenesis.

Materials and methods

Participants were recruited consecutively between November 2022 and March 2023, with acne vulgaris diagnosed by dermatologists after physical examination; only individuals free of visible lesions and scars served as controls. Exclusion criteria covered pregnancy, other facial skin disease, psoriasis or atopic eczema anywhere on the body, acne conglobata, immunodeficiency, and recent use of oral antibiotics, immunosuppressants, immunomodulators, hormones or retinoids. All participants washed exclusively with a standardised mild cleanser supplied by the investigators for at least one week beforehand, and applied no topical products for at least 12 hours before sampling. Samples were taken from the left cheek with sterile swabs pre-moistened in DNA/RNA Shield, applied with uniform pressure in vertical, horizontal and diagonal strokes across a 4 × 4 cm area for roughly 50 seconds, then transported at approximately 4°C and stored at −80°C within 24 hours. DNA was extracted using the DNeasy PowerSoil Kit, the V3–V4 region of 16S rRNA was amplified, libraries were indexed with Nextera XT and sequenced on the Illumina MiSeq platform. Bioinformatic analysis used QIIME version 1.7.0 with USEARCH filtering and denoising; operational taxonomic units entered the final analysis only if they exceeded 0.1% in a sample and appeared in at least 20% of samples. Alpha diversity was measured by the Shannon index, with Kruskal–Wallis and Mann–Whitney U tests for comparisons. The study was registered as NCT05838534 and approved by the FKUI-RSCM Health Research Ethics Committee.

Results

Of 144 participants recruited, samples from 92 acne patients and 31 controls met the minimum read threshold, with an average of 63,008 reads per sample, a mean read length of 191 bp, and 1,451 unique operational taxonomic units in total. The Shannon index was significantly lower in acne vulgaris than in controls (median 2.4, range 1.2–4.7 versus 2.96, range 1.1–4.2; p < 0.001), and fell below 3 in almost all samples. The relative abundance of C. acnes showed no meaningful difference between groups (31.8% versus 29.5%; p = 0.83). S. epidermidis was significantly more abundant in acne patients (0.2% versus 0.1%; p = 0.02), while S. aureus was not detected in any sample. Mean facial sebum excretion correlated negatively with the Shannon index (r = −0.285; p < 0.001) and positively with S. epidermidis abundance (r = 0.233; p = 0.01). Family history of acne was the only baseline characteristic that differed significantly between groups (p = 0.047).

Discussion

The lower Shannon index in acne patients points to reduced diversity and dysbiosis, which may permit pathogenic organisms to expand; commensal organisms help educate innate and adaptive immunity, so disruption of that composition can shift the skin towards a pro-inflammatory state. The absence of a difference in overall C. acnes abundance supports the view that acne relates more to particular strains than to total load — strain-level analysis would require whole genome sequencing, which this study did not perform. S. aureus was absent from all samples, consistent with reports that it is typically recovered from throat or nasal swabs rather than facial skin. The role of the elevated S. epidermidis remains unclear: it may compete with C. acnes through antimicrobial peptide production, though no reduction in C. acnes was observed here, or its biofilm formation may block sweat glands and provoke inflammation. Other commensals identified included S. cohnii, C. macginleyi, S. caprae and S. hominis, some of which can act as opportunistic pathogens. The negative correlation between sebum level and microbial diversity mirrors findings from a comparable study in India.

Conclusion

This study demonstrates significant differences in the skin microbiome of acne vulgaris patients compared with healthy individuals, most clearly in the Shannon index, which indicates decreased microbial diversity. Despite the absence of change in C. acnes proportion, the rise in rare bacteria and the higher prevalence of S. epidermidis suggest complex interactions influencing inflammation and skin health, and physiological factors such as sebum level demonstrably shape microbial composition. These insights into acne-associated dysbiosis provide a foundation for future microbiome-based therapeutic approaches.

References

Literature cited by the authors on the source poster.

  1. 1.Ramasamy S, Barnard E, Dawson TL, Li H. The role of the skin microbiota in acne pathophysiology. Br J Dermatol. 2019;181(4):691-699.
  2. 2.Barnard E, Shi B, Kang D, Craft N, Li H. The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci Rep. 2016;6:39491.
  3. 3.Lee YB, Byun EJ, Kim HS. Potential role of the microbiome in acne: a comprehensive review. J Clin Med. 2019;8(7):987.
  4. 4.Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754.
  5. 5.Manurung THP, Sitohang IBS, Agustin T. Staphylococcus caprae and Staphylococcus epidermidis define the skin microbiome among different grades of acne vulgaris. Arch Dermatol Res. 2024;317(1):156.

Acknowledgement

This research was fully funded by Paragon Technology and Innovation, Ltd. (Grant No. HK.02.03/2.2/37409/2022). The authors acknowledge the Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, and the health personnel of the Department of Dermatology and Venereology and the Clinical Research and Supporting Unit. The authors report no conflicts of interest. Cite as: Sitohang IBS, Legiawati L, Widaty S, Nilasari H, Agustin T, Chairunnisa S, Manurung THP. Comparative profile of microbiome in normal skin and acne vulgaris skin patients. Clin Cosmet Investig Dermatol. 2026;19. https://doi.org/10.2147/CCID.S549168 . The article is published by Dove Medical Press under a CC BY-NC 4.0 licence ( https://creativecommons.org/licenses/by-nc/4.0/ ) and is available from the publisher; the summary, key findings and section text on this page were written by Laboré from the published results.

Back to all studies